Streptococcus agalactiae from Ethiopian pregnant women; prevalence, associated factors and antimicrobial resistance: alarming for prophylaxis

Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: revised guidelines from CDC. MMWR. 2010;59(No. RR-10):1–36.

Woldu ZL, Teklehaimanot TG, Waji ST, Gebremariam MG. The prevalence of Group B streptococus recto-vaginal colonization and antimicrobial susceptibility pattern in pregnant mothers at two hospitals of Addis Ababa, Ethiopia. Reprod Health. 2014;11(80):1–4.

Mohammed M, Asrat D, Woldeamanuel Y, Demissie A. Prevalence of group B streptococcus colonization among pregnant women attending antenatal clinic of Hawassa Health Center, Hawassa, Ethiopia. Ethiop J Health Dev. 2012;26(1):36–42.

Russell NJ, Seale AC, Seale AC, O’Driscoll M, O’Sullivan C, Bianchi-Jassir F, Gonzalez-Guarin J, et al. Maternal colonization with group B streptococcus and serotype distribution worldwide: systematic review and meta-analyses. Clin Infect Dis. 2017;65(suppl_2):S100–11.

Seale AC, Koech AC, Sheppard AE, Barsosio HC, Langat J, Anyango E, et al. Maternal colonisation with Streptococcus agalactiae, and associated stillbirth and neonatal disease in coastal Kenya. Nat Microbiol. 2016;1(7):16067.

Lekala LM, Mavenyengwa RT, Moyo SR, Lebelo SL, Bolukaoto JY, Chukwu MO, et al. Risk factors associated with group B streptococcus colonization and their effect on pregnancy outcome. J Gynecol Obstet. 2015;3:121–8.

Sharmila V, Joseph NM, Babu TA, Chaturvedula L, Sistla S. Genital tract group B streptococcal colonization in pregnant women: a South Indian perspective. J Infect Dev Ctries. 2011;5(8):592–5.

Lambiase A, Agangi A, Del Pezzo M, Quaglia F, Testa A, Rossano F, et al. In vitro resistance to macrolides and clindamycin by group B streptococcus isolated from pregnant and non-pregnant women. Infect Dis Obstet Gynecol. 2012;2012:1–5.

Barcaite E, Bartusevicius A, Tameliene R, Kliucinskas M, Maleckiene L, Nadisauskiene R. Prevalence of maternal group B streptococcal colonization in European countries. Acta Obstet Gynecol Scand. 2008;87(3):260–71.

Seale AC, Bianchi-Jassir F, Russell NJ, Kohli-Lynch M, Tann CJ, Hall J, et al. Estimates of the burden of group B streptococcal disease worldwide for pregnant women, stillbirths, and children. Clin Infect Dis. 2017;65(suppl_2):S200–19.

Madzivhandila M, Adrian PV, Cutland CL, Kuwanda L, Schrag SJ, Madhi SA. Serotype distribution and invasive potential of group B streptococcus isolates causing disease in infants and colonizing maternal-newborn dyads. PLoS ONE. 2011;6(3):e17861.

Bergseng H, Bevanger L, Rygg M, Bergh K. Real-time PCR targeting the sip gene for detection of group B streptococcus colonization in pregnant women at delivery. J Med Microbiol. 2007;56:223–8.

Mavenyengwa RT, Moyo SR, Nordbø SA. Streptococcus agalactiae colonization and correlation with HIV-1 and HBV seroprevalence in pregnant women from Zimbabwe. Eur J Obstet Gynecol Reprod Biol. 2010;150:34–8.

Liddy H, Holliman R. Group B streptococcus highly resistant to gentamicin. J Antimicrob Chemother. 2002;50(1):42–3.

Bolukaoto JY, Monyama CM, Chuku MO, Lekala SM, Nechabeleng M, Maloba MRB, et al. Antibiotic resistance of Streptococcus agalactiae isolated from pregnant women in Garankuwa, South Africa. BMC Res Notes. 2015;8:364.

Garland SM, Cottrill E, Markowski L, Pearce C, Clifford V, Ndisang D, et al. Antimicrobial resistance in group B streptococcus: the Australian experience. J Med Microbiol. 2011;60(Pt 2):230–5.

Mengist HM, Zewdie O, Belew A, Dabsu R. Prevalence and drug susceptibility pattern of group B Streptococci (GBS) among pregnant women attending antenatal care (ANC) in Nekemte Referral Hospital (NRH), Nekemte, Ethiopia. BMC Res Notes. 2017;10:388.

Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 27th ed. CLSI supplement M100. Wayne: Clinical and Laboratory Standards Institute. 2017;37(1):84–7.

Desjardins M, Delgaty KL, Ramotar K, Seetaram C, Toye B. Prevalence and mechanisms of erythromycin resistance in group A and group B streptococcus: implications for reporting susceptibility results. J Clin Microbiol. 2004;42(12):5620–3.

Mavenyengwa RT, Afset JE, Schei B, Berg S, Caspersen T, Bergseng H, et al. Group B streptococcus colonization during pregnancy and maternal-fetal transmission in Zimbabwe. Acta Obstet ricia et Gynecol. 2010;89:250–5.

El Aila NA, Esleem SE, Elmanama AA. Prevalence of group B streptococcus colonization among pregnant women in Gaza strip, Palestine. IUG J Nat Stud. 2017;25(3):1–12.

Romanik M, Nowosielski K, Poręba R, Sioma-Markowska U, Martiroisian G, Groborz J. Streptococcus group B serotype distribution in anovaginal isolates of women in term pregnancy. Neuro Endocrinol Lett. 2014;35(4):301–5.

Mitima KT, Ntamako S, Birindwa AM, Mukanire N, Kivukuto JM, Tsongo K, et al. Prevalence of colonization by Streptococcus agalactiae among pregnant women in Bukavu, Democratic Republic of the Congo. J Infect Dev Ctries. 2014;8(9):1195–200.

Bakhtiari R, Dallal MS, Mehrabadi J, Heidarzadeh S, Pourmand M. Evaluation of culture and PCR methods for diagnosis of group B streptococcus carriage in Iranian pregnant women. Iran J Public Health. 2012;41(3):65–70.

Tsolia M, Psoma M, Gavrili S, Petrochilou V, Michalas S, Legakis N, et al. Group B streptococcus colonization of Greek pregnant women and neonates: prevalence, risk factors and serotypes. Clin Microbiol Infect. 2003;9:832–8.

Namugongo A, Joel Bazira J, Fajardot Y, Joseph N. Group B streptococcus colonization among pregnant women attending antenatal care at tertiary hospital in Rural Southwestern Uganda. Int J Microbiol. 2016;16:1–7.

Darabi R, Tadi S, Mohit M, Sadeghi E, Hatamizadeh G, Kardeh B, et al. The prevalence and RSK factors of group B streptococcus colonization in Iranian pregnant women. Electr Phys. 2017;9(5):4399–404 (ISSN: 2008 - 5842).

Onwuezobe IA, Effiom RA. Prevalence and associated risk factors of group B streptococcus in pregnant women attending antenatal care in a Nigerian urban hospital. Ibom Med J. 2016;9(1):1–7.

Le Doare K, Jarju S, Darboe S, Warburton F, Gorringe A, Heath PT, et al. Risk factors for group B streptococcus colonisation and disease in Gambian women and their infants. J Infect. 2016;72(3):283–94.

Kovavisarach E, Ying WS, Kanjanahareutai S. Risk factors related to group B streptococcal colonization in pregnant women in labor. J Med Assoc Thail. 2007;90(7):1287–92.

Patil KP, Singla SS, Nagmoti MB, Swamy MK. Group B Streptococci colonization in pregnant women: is screening necessary? J South Asian Feder Obstet Gynaecol. 2013;5(2):64–7.

Mengist A, Kannan H, Abdissa A. Prevalence and antimicrobial susceptibility pattern of anorectal and vaginal group B Streptococci isolates among pregnant women in Jimma, Ethiopia. BMC Res Notes. 2016;9:351.

Gebremeskel TK, Zeleke TA, Mihret A, Tikue MD. Prevalence and antibiotic susceptibility pattern of Streptococcus agalactiae among pregnant women at Adigrat Zonal Hospital and Adigrat Health Center, Tigray, Ethiopia. J Gynecol Obstet. 2015;3(2):29–35.

Joachim A, Matee MI, Massawe FA, Lyamuya EF. Maternal and neonatal colonisation of group B streptococcus at Muhimbili National Hospital in Dar es Salaam, Tanzania: prevalence, risk factors and antimicrobial resistance. BMC Public Health. 2009;9:437.

Vinnemeier CD, Brust P, Owusu-Dabo E, Sarpong N, Sarfo EY, Bio Y, et al. Group B Streptococci serotype distribution in pregnant women in Ghana: assessment of potential coverage through future vaccines. Trop Med Int Health. 2015;20(11):1516–24.

Lu B, Li D, Cui Y, Sui W, Huang L, Lu X. Epidemiology of Group B streptococcus isolated from pregnant women in Beijing, China. Clin Microbiol Infect. 2014;20:0370–3.

Melo SCCS, Santos NCS, Oliveira M, Scodro RBL, Cardoso RF, Pádua RAF, et al. Antimicrobial susceptibility of Streptococcus agalactiae isolated from pregnant women. Rev Inst Med Trop Sao Paulo. 2016;58:83.

Rao GG, Nartey G, McAree T, O’Reilly A, Hiles S, Lee T, et al. Outcome of a screening programme for the prevention of neonatal invasive early-onset group B Streptococcus infection in a UK maternity unit: an observational study. BMJ. 2017;7:e014634.

Gygax SE, Schuyler JA, Kimmel LE, Trama JP, Mordechai E, Adelson ME. Erythromycin and clindamycin resistance in group B streptococcal clinical isolates. Antimicrob Agents Chemother. 2006;50(5):1875–7.

Berg BR, Houseman JL, LeBar WD, Newton DW. Antimicrobial susceptibilities of group B Streptococcus isolates from prenatal screening samples. J Clin Microbiol. 2014;52(9):3499–500.

Back EE, O’Grady EJ, Back JD. High rates of perinatal group B Streptococcus clindamycin and erythromycin resistance in an upstate New York hospital. Antimicrob Agents Chemother. 2012;56:739–42.

Lee BK, Song YR, Kim MY, Yang JH, Shin JH, Seo YS, et al. Epidemiology of group B streptococcus in Korean pregnant women. Epidemiol Infect. 2010;138(2):292–8.

Hraoui M, Boubaker IBB, Rachdi M, Slim A, Redjeb SB. Macrolide and tetracycline resistance in clinical strains of Streptococcus agalactiae isolated in Tunisia. J Med Microbiol. 2012;61:1109–13.

Emaneini M, Mirsalehian A, Beigvierdi R, Fooladi AA, Asadi F, Jabalameli F, et al. High incidence of macrolide and tetracycline resistance among Streptococcus agalactiae strains isolated from clinical samples in Tehran, Iran. Maedica (Buchar). 2014;9:157–61.

Saffar H, Rajabiani A, Abdollahi A, Habibi S, Baseri Z. Frequency of inducible clindamycin resistance among gram-positive cocci in a tertiary hospital, Tehran, Iran. Iran J Microbiol. 2016;8(4):243–8.